BlackRock Fund Advisors’s Cytosorbents Corp CTSO Stock Holding History

BlackRock Fund Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$351K	Buy	64,489 +10,682	+20%	+$58.5K	﹤0.01%	3294
2016 Q3	$344K	Sell	53,807 -108	-0.2%	-$561	﹤0.01%	3303
2016 Q2	$245K	Buy	53,915 +15,203	+39%	+$66.2K	﹤0.01%	3390
2016 Q1	$152K	Sell	38,712 -2,884	-7%	-$12.5K	﹤0.01%	3557
2015 Q4	$232K	Buy	41,596 +1,801	+5%	+$12.3K	﹤0.01%	3474
2015 Q3	$251K	Sell	39,795 -1,050	-3%	-$7K	﹤0.01%	3389
2015 Q2	$251K	Buy	+40,845	New	+$278K	﹤0.01%	3435

Other funds holding CTSO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

MHP

Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock Fund Advisors's CTSO Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Cytosorbents Corp (CTSO) stake by 20% in Q4 2016, buying an estimated $58.5K and bringing the position to 64,489 shares worth $351K. The position accounts for ﹤0.01% of the portfolio, ranked #3294.

BlackRock Fund Advisors first reported a position in CTSO in Q2 2015 and has held it in 7 quarters since. 38 funds tracked by Wall St. Rank hold CTSO as of Q4 2016.

BlackRock Fund Advisors held 64,489 shares of Cytosorbents Corp worth $351K as of Q4 2016.
BlackRock Fund Advisors bought 10,682 Cytosorbents Corp shares in Q4 2016, an estimated $58.5K.
Cytosorbents Corp made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3294 holding.
BlackRock Fund Advisors first reported a position in Cytosorbents Corp in Q2 2015 and has held it in 7 quarters since.
38 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.